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1. Introduction 
Considerable amounts of glucose 1, 6-diphosphate 
(Glc-1 ,6-PZ) exist in mammalian erythrocytes [l-3], 
mainly as a result of the phosphoglucomutase reaction 
[2,3]. It is involved in glycolysis by its positive effects 
on phosphofructokinase [4] and pyruvate kinase [5] 
and by its inhibitory action on hexokinase [6,7]. The 
inhibition constants reported for hexokinase type I 
from human erythrocytes [6,7] are well in or below 
the range of the intracellular concentrations [l-3], 
suggesting a role for Glc-1 ,6-PZ in-regulation of 
hexokinase activity in vivo. In contrast Beitner et al. 
[8] reported that Glc-1,6-P* exerted a selective 
inhibitory effect on hexokinase type II and had no 
effect on type I hexokinase. 
A striking pH-dependency of the inhibition by 
Glc-1,6-P* was reported by Rose and Warms [9] for 
hexokinase type II from Ehrlich-Lettre’ hyperdiploid 
cells and for hexokinase type I from Sarcoma 37 cells. 
Recently we reported [lo] that the inhibition of 
purified hexokinase from human erythrocytes by 
glucose 6-phosphate and fructose 6-phosphate is 
strongly regulated by inorganic phosphate. In this 
paper we show that the inhibition of human erythrocyte 
hexokinase by Glc-1 ,6-PZ is similarly regulated by 
inorganic phosphate and that the same pH-dependency 
exists as reported by Rose and Warms [9] for hexo- 
kinase from Ehrlich-Lettrd and Sarcoma 37 cells. 
2. Materials and methods 
Glucose 1,6-diphosphate (Glc-1 ,6-PZ , tetracyclo- 
hexylammonium salt), ATP (disodium salt), NADP+ 
(disodium salt) and glucose-6-phosphate dehydrogenase 
were obtained from Boehringer, Mannheim. NaH2P04 
(Pi) and all other chemicals were of analytical grade 
of purity. 
Human erythrocyte hexokinase was purified as 
reported earlier [ 111, with a specific activity of 35 
U/mg of protein. The enzyme solution contained 
0.05 M Tris-HCl (pH = 8.0), 0.5 M NaCl and 0.003 M 
fl-mercaptoethanol. 
Hexokinase activity was determined at 37°C in a 
system coupled with glucose-6-phosphate dehydrogenase 
as described before [lo]. MgClz was added in the 
concentrations necessary to maintain an excess of 
5 mM Mg?’ over ATP. The concentration of glucose 
was 10 mM. The pH of the assay buffer ranged from 
6.8-8.3. All pH values were determined at 37°C in the 
complete reaction mixture. The reaction was started 
by adding 0.03 units of hexokinase. One unit of 
enzyme activity is defined as the amount of enzyme 
which catalyzes the formation of 1 bmol of glucose 
6-phosphate per min at 37°C. 
Inhibition constants were calculated from double 
reciprocal plots of enzyme activity vs. [MgATP2-] in 
the presence and absence of Glc-1,6-P2 at a concen- 
tration near the Ki. These plots have been statistically 
treated as described before [ 121. 
3. Results 
Human erythrocyte hexokinase is inhibited by 
Glc-1,6-P, competitively with respect to MgATP2- 
(fig.l). The secondary plot of slope of the Lineweaver- 
Burke plots vs. inhibitor concentration is linear up 
to inhibitor concentrations of about twice the 
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Fig.1. Lineweaver-Burk plots of hexokinase activity vs. [MgATP*-] at concentrations of Glc-1,6-P, of 0.0 mM (*),0.05 mM CA), 
0.2 mM (o), 0.3 mM (x), 0.4 mM (m), 0.5 mM (A) and 0.9 mM (0). pH = 7.7. Inset: Secondary plot of slope vs. added Glc-1,6-P,. 
Ki (inset fig.1). At higher concentrations the curve 
bends upwards. Inorganic phosphate was able to 
overcome, at least partly, the inhibition by Glc-1, 
6-P* (fig.2). This influence of Pi is competitive 
with respect to Glc-1 ,6-P2. A similar pattern of 
inhibition and a similar influence of Pi was found 
either at pH 7.7 (figs. 1 and 2) or at pH 7.15 (results 
not shown), although Ki Glc-1,6-Pz was much lower 
at pH 7.15 (see below). 
Using modified Michaelis-Menten equations the 
influence of Pi on the inhibition constant of an 
inhibitor could be described in terms of enzyme 
activity in presence and absence of inhibitor as a 
function of Pi [ 101. If Pi competes completely with 
the inhibitor, the function equals f(Pi) = 1 + Pi/KP.. 
However the funtion describing the influence of Pi’ 
on the inhibitor by Glc-1,6-P, is not linear (fig.3), 
reflecting the inability of Pi to overcome the inhibition 
completely. Ki Glc-1 ,6-PZ is maximally increased by 
a factor of about 3 at pH 7.7 and by a factor of about 
4 at pH 7.15 at higher concentrations of Pi. From the 
linear part of the function the activation constant of 
Pi, Kpi, can be calculated. Up to concentrations of about 
1 mM Pi the activation constant of Pi is approx. 0.8 
mM at both pH values. 
Figure 4 shows that the inhibition by Glc-1 ,6-PZ 
is pH dependent, the inhibition constant increases 
exponentially above pH 7.0. The inhibition was 
competitive towards MgATP’- at all pH values tested. 
The inhibion by glucose 6-phosphate, fructose 6-phos-- 
phate and fructose 1,6-diphosphate, observed at pH 
7.7 [lo] was not pH-dependent. 
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Fig.2. Influence of Pi on the inhibition by Glc-1, 6-P, at pH 7.7. The reciprocal of hexokinase activity is plotted vs. the reciprocal 
of [ MgATP’-] ‘In the presence (A,q,e) and absence (0) of 0.5 mM Glc-1, 6-P,. The concentrations of added phosphate are 0.0 mM 
(*,a), 0.2 mM (A), 0.8 mM (0) and 5.0 mM (e). 
J 
0 0 
fi- 
4. Discussion 
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The results show that the competitive inhibition 
D of human erythrocyte hexokinase by Glc-1 ,6-Pz . 
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with respect to MgATP*- is similarly regulated by 
phosphate as the inhibition by glucose-6-P and fructose- 
6-P described previously [lo]. To explain the effects 
of Pi a model, proposed by Ellison et al. [ 131 for 
brain hexokinase, was modified: hexokinase exists in 
Fig.3. Influence of Pi on the inhibition by Glc-1, 6-P, by 0.5 
CPiI (mM) mM Glc-1, 6-P, at pH 7.7 (0) and by 0.1 mM Glc-1, 6-P, at 
i0 1; 
pH 7.15 (0). f(Pi) is determined as defined in the text. 
[MgATPZ-] ‘was kept constant at 0.5 mM. 
63 
Volume 80, number 1 FEBS LETTERS August 1911 
i 
K;Glc-1.6-Pa f 
Fig.4. Influence of pH on the inhibition constant of Glc-1, 
6-P,. The values for Ki and the standard error of Ki (brackets) 
are calculated as described in Materials and methods. 
equilibrium between a free and a phosphate associated 
form with the same kinetic properties except in their 
ability to bind hexose-phosphate. The phosphate asso- 
ciated form has a reduced but still substantial affinity 
for the inhibitor. An alternative explanation of the 
results is the presence of two different enzymes, one 
with a high affinity for hexose-phosphate, being sensi- 
tive to regulation by Pi, one with a lower affinity for 
hexosephosphate being insensitive to Pi; the Km 
MgATP2 - being the same for both enzymes. The 
secondary plot of fig. 1, which is deviating from 
linearity at higher concentrations of Glc-1,6-P2 
is in favour of the latter model. 
The pH-dependency of the inhibition of human 
erythrocyte hexokinase by Glc-1,6-P? is completely 
in agreement with the results of Rose and Warms 
[9] on hexokinase from Ehrlich-Lettre and Sarcoma 
37 cells. They argued that the loss of inhibition at 
higher pH is attributed to the appearance of an addi- 
tional negative charge. The phosphate-group at the 
Cr -atom is bound to the enzyme as a mono-anion but 
is excluded as a dianion. 
At pH 7.2, the intracellular pH of the red blood 
cell, the inhibition constant of Glc-1,6-P, is about 
50 FM. This value is measured at a concentration of 
5 mM of free Mg”. Under in vivo conditions this 
inhibition constant may even be lower, because 
intracellular concentrations of free Mg2’(approx. 
0.7 mM, ref. [ 141) minimize the formation of Mg-Glc-1, 
6-P2 (Kdm-;= 2.5 mM), which is not inhibitory [9]. 
The value Of Ki is well below the range of intracellular 
concentrations of Glc-1,6-P2 (SO- 150) PM, ref. [l-3], 
suggesting an important role for Glc-I ,6-P2 in regula- 
ting hexokinase activity in vivo. From this data it is 
probable that Glc-1,6-P* is at least as important in 
regulating hexokinase activity in vivo as is glucose-6-P. 
Because Pi exerts its most pronounced effects in the 
range of its physiological concentration, the impor- 
tance of Pi in regulating hexokinase activity is once more 
demonstrated. 
The strong pH-dependency of the inhibition of 
human erythrocyte hexokinase by Glc-1,6-P2 suggests 
that red cell glycolysis is influenced by pH not only 
at the phosphofructokinase step but also at the 
hexokinase step. 
In glucosephosphate isomerase (GPI) deficiency 
increased levels of glucose 6-phosphate and an increased 
formation of glycogen in erythrocytes and liver are 
reported [ 1.51. The latter suggests that in addition to 
the increased level of glucose-6-P the amount of 
Glc-1,6-P2 might be increased too. Defective GPI thus 
may affect strongly the regulation of hexokinase, 
which may account for its strong impact on erythrocyte 
mechanism reflected in severe haemolysis. On the 
contrary the formation of Pi during glycogen formation 
will have a positive effect on hexokinase activity. 
Unfortunately there is little information available 
about the red cell contents of Glc-1,6-P? and Pi in 
GPI-deficiency. 
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